Common use of Audit Dispute Clause in Contracts

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.10, AbbVie and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***], the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] after such decision and in accordance with such decision, Licensee shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9, or AbbVie shall reimburse the excess payments, as applicable.

Appears in 2 contracts

Samples: License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Gemini Therapeutics, Inc. /DE)

AutoNDA by SimpleDocs

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.10audit, Caribou and AbbVie and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***]] days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] days after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9due, or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 2 contracts

Samples: Collaboration and License Agreement (Caribou Biosciences, Inc.), Collaboration and License Agreement (Caribou Biosciences, Inc.)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.104.11, AbbVie AstraZeneca and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [* * ***]] days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit ArbitratorAuditor”). The decision of the Audit Arbitrator Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator Auditor shall determine. Not later than [*** * *] days after such decision and in accordance with such decision, Licensee shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9, 4.9 or AbbVie AstraZeneca shall reimburse the excess payments, as applicable.

Appears in 2 contracts

Samples: Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.), Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.106.13, Licensor and AbbVie and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***]] days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] days after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.96.12, or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 2 contracts

Samples: Development and License Agreement, Development and License Agreement (Principia Biopharma Inc.)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.106.8, AbbVie Licensor and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***]] days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] days after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.96.6, or AbbVie the auditing Party shall reimburse the such excess payments, as applicable.

Appears in 2 contracts

Samples: License Agreement (Reata Pharmaceuticals Inc), License Agreement (Reata Pharmaceuticals Inc)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.108.12, AbbVie REGENX and Licensee PARTNER shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [****], the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit ArbitratorAuditor”). The decision of the Audit Arbitrator Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator Auditor shall determine. Not later than [****] after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.98.10, or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 1 contract

Samples: Collaboration and License Agreement (REGENXBIO Inc.)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.106.8, AbbVie Licensor and Licensee shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***]] days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator“ Arbitrator ”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] days after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.96.6, or AbbVie the auditing Party shall reimburse the such excess payments, as applicable.

Appears in 1 contract

Samples: License Agreement (Reata Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.105.10, AbbVie Licensor and Licensee AstraZeneca shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***], the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit ArbitratorAuditor”). The decision of the Audit Arbitrator Auditor shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator Auditor shall determine. Not later than [***] after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9, 5.8 or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 1 contract

Samples: License Agreement (F-Star Therapeutics, Inc.)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.10‎8.10, AbbVie Xencor and Licensee Genentech shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***], either Party may submit the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9, ‎8.9 or AbbVie the auditing Party shall reimburse the excess payments, as applicable.. CONFIDENTIALEXECUTION COPY

Appears in 1 contract

Samples: Collaboration and License Agreement (Xencor Inc)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.108.10, AbbVie Xencor and Licensee Genentech shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***], either Party may submit the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.9, 8.9 or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 1 contract

Samples: Collaboration and License Agreement (Xencor Inc)

Audit Dispute. In the event of a dispute with respect to any audit under Section 4.1011.7.4, AbbVie Adaptimmune and Licensee GNE shall work in good faith to resolve the disagreement. If the Parties are unable to reach a mutually acceptable resolution of any such dispute within [***]] days, either Party may submit the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party’s certified public accountants or to such other Person as the Parties shall mutually agree (the “Audit Arbitrator”). The decision of the Audit Arbitrator shall be final and the costs of such arbitration as well as the initial audit shall be borne between the Parties in such manner as the Audit Arbitrator shall determine. Not later than [***] after such decision and in accordance with such decision, Licensee the audited Party shall pay the additional amounts, with interest from the date originally due as provided in Section 4.911.7.4 (Underpayment; Overpayment), or AbbVie the auditing Party shall reimburse the excess payments, as applicable.

Appears in 1 contract

Samples: Strategic Collaboration and License Agreement (Adaptimmune Therapeutics PLC)

Time is Money Join Law Insider Premium to draft better contracts faster.